NCT07155226 2026-03-18
MOMENTUM
AstraZeneca
Phase 1/2 Recruiting
AstraZeneca
BeOne Medicines
Shandong Cancer Hospital and Institute
Nantes University Hospital
Centre Hospitalier Universitaire Vaudois
Institute of Hematology & Blood Diseases Hospital, China